The multiplicative interactions of leukocyte counts with some other risk factors enhance the prognostic value for coronary artery disease

Cardiology Journal

Volumn 18, Issue 3, 2011, Pages 246-253

  Rasouli, Mehdi ^a   Nesarhosseini, Vida ^a   Kiasari, Asadollah Mohseni ^a   Arab, Shahin ^a   Shariati, Ramin ^b   Kazemi, Davood ^b   Daneshpour, Nezhatossadateh ^b   Heidari, Sareh ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

ApoB; Coronary artery disease; Diabetes mellitus; Hypertension; Leukocyte count; Smoking

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; APOLIPOPROTEIN; APOLIPOPROTEIN A1; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; NITRATE; PHOSPHORUS; POTASSIUM; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PREVALENCE; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 79959315346     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease. Implications for risk assessment. J Am Coll Cardiol, 2004; 44: 1946-1956.
2. Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclosis, 2004; 172: 1-6.
3. Wheeler JG, Mussolino ME, Gillum RF, Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J, 2004; 25: 1287-1292.
4. Kaptoge S, Di Angelantonio E, Lowe G et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet, 2010; 375: 132-140.
5. Rana JS, Boekholdt SM, Ridker PM et al. Differential leukocyte count and the risk of future coronary artery disease in healthy men and women: The EPIC-Norfolk Prospective Population Study. J Intern Med, 2007; 262: 678-689.
6. Park CS, Ihm SH, Yoo KD et al. Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA. Am J Cardiol, 2010; 105: 1284-1288.
7. Margolis KL, Manson JE, Greenland P et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: The Women's Health Initiative Observational Study. Arch Intern Med, 2005; 165: 500-508.
8. Brown DW, Giles WH, Croft JB. White blood cell count: An independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol, 2001; 54: 316-322.
9. Hasegawa T, Negishi T, Deguchi M. WBC count, atherosclerosis and coronary risk factors. J Atheroscler Thromb, 2002; 9: 219-223.
10. Giugliano G, Brevetti G, Lanero S et al. Leukocyte count in peripheral arterial disease: A simple, reliable, inexpensive approach to cardiovascular risk prediction. Atherosclerosis, 2010; 210: 288-293.
11. Arain FA, Khaleghi M, Bailey KR et al. White blood cell count predicts all-cause mortality in patients with suspected peripheral arterial disease. Am J Med, 2009; 122: 874.e1-874.e7.
12. Roy D, Quiles J, Avanzas P et al. A comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndrome. Int J Cardiol, 2006; 109: 317-321.
13. Dragu R, Huri S, Zuckerman R et al. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis, 2008; 196: 405-412.
14. Koren-Morag N, Tanne D, Goldbourt U. White blood cell count and the incidence of ischemic stroke in coronary heart disease patients. Am J Med, 2005; 118: 1004-1009.
15. Li C, Engström G, Hedblad B. Leukocyte count is associated with incidence of coronary events, but not with stroke: A prospective cohort study. Atherosclerosis, 2010; 209: 545-550.
16. Yip HK, Wu CJ, Hang CL et al. Levels and values of inflammatory markers in patients with angina pectoris. Int Heart J, 2005; 46: 571-581.
17. Takeda Y, Suzuki S, Fukutomi T et al. Elevated white blood cell count as a risk factor of coronary artery disease: Inconsistency between forms of the disease. Jpn Heart J, 2003; 44: 201-211.
18. Takahashi T, Hiasa Y, Ohara Y et al. Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction. Circ J, 2008; 72: 867-872.
19. Huang G, Zhong XN, Zhong B et al. Significance of white blood cell count and its subtypes in patients with acute coronary syndrome. Eur J Clin Invest, 2009; 39: 348-358.
20. Haumer M, Amighi J, Exner M et al. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. J Vasc Surg, 2005; 41: 610-617.
21. Kawaguchi H, Mori T, Kawano T et al. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J, 1996; 132: 9-12.
22. Horne BD, Anderson JL, John JM et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol, 2005; 45: 1638-1643.
23. Gillum RF, Mussolino ME, Madans JH. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: The NHANES-I epidemiologic follow-up study. Ann Epidemiol, 2005; 15: 266-271.
24. Papa A, Emdin M, Passino C et al. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta, 2008; 395: 27-31.
25. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation, 1998; 97: 2007-2011.
26. Rifai N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem, 2001; 47: 28-30.
27. Rasouli M, Mohseni AK, Bagheri B. Total and differential leukocytes counts, but not hsCRP, ESR, and five fractioned serum proteins have significant potency to predict stable coronary artery disease. Clin Chem Acta, 2007; 377: 127-132.
28. Rasouli M, Mohseni AK, Arab S. Indicators of dehydration and hemoconcentration are associated with the prevalence and severity of coronary artery disease. Clin Exp Physiol Pharm, 2008; 43: 635-640.
29. Rasouli M, Kiasari AM, Mokhberi V. The ratio of apoB/apoAI, apoB and Lp(a) are the best predictors of stable coronary artery disease. Clin Chem Lab Med, 2006; 44: 1015-1021.
30. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple risk factor assessment equations. A statement for healthcare professionals from the american heart association and the american college of cardiology. J Am Coll Cardiol, 1999; 34: 1348-1359.
31. Aronson D, Bartha P, Zinder O et al. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med, 2004; 21: 39-44.
32. Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB. C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care, 2004; 27: 889-894.
33. Aronson D, Goldberg A, Roguin A et al. Effect of obesity on the relationship between plasma C-reactive protein and coronary artery stenosis in patients with stable angina. Atherosclerosis, 2006; 185: 137-142.
34. Florez H, Castillo-Florez S, Mendez A et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Prac, 2006; 71: 92-100.
35. Maat MPM, Kluft C. The association between inflammation markers, coronary artery disease and smoking. Vasc Pharm, 2002; 39: 137-139.
36. Sunyer J, Munoz A, Peng Y et al. Longitudinal relation between smoking and white blood cells. Am J Epidemiol, 1996; 144: 734-741.
37. Piché MP, Lemieux S, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol, 2005; 96: 92-97.
38. Rasouli M, Mohseni AK. Interactions of serum hsCRP with apoB, apoB/apoAI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease. Clin Biochem, 2006; 39: 971-977.